Shares of Nemaura Medical Inc. (OTCMKTS:NMRD – Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as $214,748.3647 and last traded at $214,748.3647, with a volume of 2 shares traded. The stock had previously closed at $0.0001.
Nemaura Medical Stock Up 214,748,364,600.0%
The stock has a market cap of $8.67 trillion, a PE ratio of -550,622.71 and a beta of 0.88.
About Nemaura Medical
Nemaura Medical PLC is a medical technology company focused on developing non‐invasive monitoring solutions for diabetes management and other metabolic applications. The company’s core offering centers on sugarBEAT, a wearable continuous glucose monitoring (CGM) system designed to provide real-time glucose readings through a disposable skin patch. By eliminating the need for finger-stick testing, Nemaura aims to improve patient comfort and adherence, particularly for individuals managing type 1 and type 2 diabetes.
The sugarBEAT system utilizes a proprietary, mild electric current to extract interstitial fluid through micro-pores in the skin, enabling glucose measurement without needle penetration.
Recommended Stories
- Five stocks we like better than Nemaura Medical
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Trump Planning to Use Public Law 63-43: Prepare Now
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Receive News & Ratings for Nemaura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nemaura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
